Aptahem
0.87 SEK
-8.03 %
Less than 1K followers
APTA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-8.03 %
-8.81 %
-24.02 %
0.00 %
-40.00 %
+43.92 %
-96.98 %
-99.24 %
-99.83 %
Aptahem operates in the pharmaceutical industry. The company develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's lead candidate is being developed as an emergency drug intended to prevent the onset of life-threatening organ and tissue damage in patients suffering from sepsis. A large part of the research is carried out in collaboration with partners in the industry. The company was founded in 2014 and is headquartered in Malmö.
Read moreMarket cap
18.25M SEK
Turnover
4.85K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27/3
2026
General meeting '26
28/5
2026
Interim report Q1'26
All
Press releases
3rd party
ShowingAll content types
Kallelse till årsstämma i Aptahem AB (publ)
Aptahems bokslutskommuniké 2025-01-01 till 2025-12-31
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools